Med Clin North Am. 1990 Jul;74(4):859-71. doi: 10.1016/s0025-7125(16)30522-3.
PMID:2195258
AMP-activated protein kinase alpha2 contributes to acute and chronic hyperuricemic nephropathy via renal urate deposition in a mouse model.
Yang C, Su HY, An N, Wu HL, Guo XY, Li ZH, Chen XC, Zhu SP, Wu D, Li HY, Pan QJ, Liang D, Liu HF.
Eur J Med Res. 2022 Sep 10;27(1):176. doi: 10.1186/s40001-022-00800-1.
PMID:36088368
Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway.
Liu Y, Gong S, Li K, Wu G, Zheng X, Zheng J, Lu X, Zhang L, Li J, Su Z, Liu Y, Xie J, Chen J, Li Y.
Biomed Pharmacother. 2022 Dec;156:113941. doi: 10.1016/j.biopha.2022.113941. Epub 2022 Nov 2.
PMID:36411660
Acute uric acid nephropathy.
Robinson RR, Yarger WE.
Arch Intern Med. 1977 Jul;137(7):839-40.
PMID:879920
Hyperuricemia and gout.
German DC, Holmes EW.
Med Clin North Am. 1986 Mar;70(2):419-36. doi: 10.1016/s0025-7125(16)30961-0.
PMID:3512932
Nephrolithiasis.
Worcester EM, Coe FL.
Prim Care. 2008 Jun;35(2):369-91, vii. doi: 10.1016/j.pop.2008.01.005.
PMID:18486720
Lacticaseibacillus rhamnosus Fmb14 prevents purine induced hyperuricemia and alleviate renal fibrosis through gut-kidney axis.
Zhao H, Chen X, Zhang L, Meng F, Zhou L, Pang X, Lu Z, Lu Y.